ICU Medical (NASDAQ:ICUI) Stock: Insider Elisha Finney Sells 1,700 Shares

ICU Medical, Inc. (NASDAQ:ICUI) Director Elisha Finney sold 1,700 shares of the stock in a transaction that occurred on Friday, November 13th. The stock was sold at an average price of $179.00, for a total value of $304,300.00. Following the completion of the sale, the director owned 4,871 shares in the company, valued at approximately $871,909. The trade was a 25.87% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

ICU Medical Trading Up 1.1%

Shares of ICUI stock traded up $1.97 on Friday, reaching $179.27. 195,454 shares of the company’s stock were exchanged, compared to its average volume of 278,884. ICU Medical, Inc. has a 52 week low of $113.37 and a 52 week high of $192.85. The company has a current ratio of 2.37, a quick ratio of 1.19 and a debt-to-equity ratio of 0.52. The stock has a market capitalization of $4.48 billion, a PE ratio of 75.01, a P/E/G ratio of 2.23 and a beta of 0.88. The company’s fifty day simple moving average is $163.72 and its 200 day simple moving average is $149.91.

ICU Medical (NASDAQ:ICUI) last posted its quarterly earnings data on Thursday, November 5th. The medical instruments supplier reported $2.44 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.14 by $0.30. The company had revenue of $556.22 million during the quarter, compared to analysts’ expectations of $552.03 million. ICU Medical had a return on equity of 8.40% and a net margin of 2.76%. ICU Medical’s revenue was up 4.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.03 EPS. As a group, analysts forecast that ICU Medical, Inc. will post 7.22 EPS for the current year.

Institutional Investors Weigh In On ICU Medical

Hedge funds have recently made changes to their positions in the company. EP Wealth Advisors LLC purchased a new stake in ICU Medical in the third quarter worth about $899,000. Pathstone Holdings LLC bought a new position in ICU Medical during the 3rd quarter worth about $416,000. Marshall Wace LLP increased its position in ICU Medical by 122.9% during the 3rd quarter. Marshall Wace LLP now owns 95,391 shares of the medical instruments supplier’s stock valued at $15,311,000 after purchasing an additional 52,594 shares during the period. Empowered Funds LLC purchased a new position in ICU Medical during the 3rd quarter valued at about $1,431,000. Finally, First Trust Advisors LP raised its holdings in shares of ICU Medical by 136.6% in the 3rd quarter. First Trust Advisors LP now owns 14,996 shares of the medical instruments supplier’s stock valued at $2,407,000 after purchasing an additional 8,657 shares in the last quarter. 96.10% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

ICUI has been the topic of several recent analyst reports. KeyCorp raised their price target on shares of ICU Medical from $187.00 to $189.00 and gave the stock an “overweight” rating in a research note on Friday, November 6th. Zacks Research cut shares of ICU Medical from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, July 28th. Piper Sandler boosted their price objective on shares of ICU Medical from $195.00 to $200.00 and gave the company an “overweight” rating in a research report on Friday, November 6th. Needham & Company LLC upped their target price on shares of ICU Medical from $165.00 to $187.00 and gave the stock a “buy” rating in a research note on Friday, August 7th. Finally, Weiss Ratings raised shares of ICU Medical from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, October 8th. Two equities research analysts have rated the stock with a Strong Buy rating, four have issued a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $195.20.

About ICU Medical

ICU Medical is a medical technology company that develops, manufactures and markets products used in infusion therapy, vascular access and critical care. Its offerings include infusion pumps and related sets and accessories, IV solutions, needlefree connectors, and products designed to help protect healthcare workers when handling hazardous drugs. Founded in 1984, the company expanded its product portfolio through acquisitions, including the infusion systems business of Hospira in 2017 and Smiths Medical in 2022.